Molecular and Whole-body MR Imaging in Lymphomas
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of SEA-CD40 in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
Testing a Personalize Medication Log for Patients With Lymphoma
- Status
- COMPLETED
- Phase
- N/A
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
- Status
- COMPLETED
- Phase
- PHASE3
African American Cancer Clinical Trial Decisions: Testing Tailored Messages
- Status
- COMPLETED
- Phase
- NA
A Clinical Research of CAR T Cells Targeting CD19 Positive Malignant B-cell Derived Leukemia and Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)
- Status
- UNKNOWN
- Phase
- PHASE4
A Pilot RCT of the PRISM Intervention for AYAs With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- N/A
Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)
- Status
- COMPLETED
- Phase
- PHASE2
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
- Status
- COMPLETED
- Phase
- PHASE2
Blood Samples to Identify Biomarkers of Busulfan
- Status
- TERMINATED
- Phase
- N/A
Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection -The European Perspective
- Status
- COMPLETED
- Phase
- N/A
Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Infusion of Allogeneic, 3rd Party CD19-specific T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1